Sheela Ramamoorthy is a Veterinarian and Virologist, who obtained her Bachelors in Veterinary Medicine (BVSc) from the Madras Veterinary College in India, MS in Microbiology and Molecular Genetics from the Oklahoma State University, followed by a PhD in Biomedical Sciences from Virginia Tech. She served as the Section Head of Diagnostic Virology and Serology at the University of Georgia Tifton Veterinary Diagnostic Laboratory, before moving to N Dakota State University, where her research is focused on studying vaccine-mediated immunity against viral infections. Her well-funded research group works on translating basic findings into novel vaccines and diagnostics, for agents involved in the porcine respiratory disease syndrome. She had authored over 40 peer-reviewed publications, is a Board Member of the American Association of Veterinary Immunology, she serves as a Reviewer for reputed journals and as a Grant Reviewer for several agencies including the United States Department of Agriculture and National Institutes of Health. Sheela Ramamoorthy is a Veterinarian and Virologist, who obtained her Bachelors in Veterinary Medicine (BVSc) from the Madras Veterinary College in India, MS in Microbiology and Molecular Genetics from the Oklahoma State University, followed by a PhD in Biomedical Sciences from Virginia Tech. She served as the Section Head of Diagnostic Virology and Serology at the University of Georgia Tifton Veterinary Diagnostic Laboratory, before moving to N Dakota State University, where her research is focused on studying vaccine-mediated immunity against viral infections. Her well-funded research group works on translating basic findings into novel vaccines and diagnostics, for agents involved in the porcine respiratory disease syndrome. She had authored over 40 peer-reviewed publications, is a Board Member of the American Association of Veterinary Immunology, she serves as a Reviewer for reputed journals and as a Grant Reviewer for several agencies including the United States Department of Agriculture and National Institutes of Health.

translating basic findings into novel vaccines and diagnostics, for agents involved in the porcine respiratory disease syndrome